Wenbin Jiang Cytek Biosciences, Inc. (CTKB) insider trading activity

CTKB Quotes by TradingView

Wenbin Jiang is PRESIDENT AND CEO of Cytek Biosciences, Inc.. Currently has a direct ownership of 5.22 Million shares of CTKB, which is worth approximately $20.9 Million. The most recent transaction as insider was on Apr 07, 2022, when has been sold 20,000 shares (Common Stock) at a price of $10.54 per share, resulting in proceeds of $210,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.22M
0.72% 3M change
1.49% 12M change
Total Value Held $20.9 Million

Wenbin Jiang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 07 2022
SELL
Open market or private sale
$210,800 $10.54 p/Share
20,000 Reduced 0.25%
7,916,040 Common Stock
Mar 07 2022
SELL
Open market or private sale
$263,800 $13.19 p/Share
20,000 Reduced 0.25%
7,936,040 Common Stock
Mar 04 2022
BUY
Exercise of conversion of derivative security
$16,666 $0.25 p/Share
66,665 Added 0.83%
7,956,040 Common Stock
Feb 07 2022
SELL
Open market or private sale
$288,000 $14.4 p/Share
20,000 Reduced 0.25%
7,889,375 Common Stock
Dec 04 2021
SELL
Bona fide gift
-
5,000 Reduced 0.06%
7,842,710 Common Stock
WJ

Wenbin Jiang

PRESIDENT AND CEO
Fremont, CA

Track Institutional and Insider Activities on CTKB

Follow Cytek Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

News

Receive news related to Cytek Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CTKB